Nov 30, 2015  Stevencd

Creative Bioarray Launches Human B Cells for Global Scientific Researchers

Creative Bioarray, a global leader in the supply of research-use cells, including primary cells, tumor cells, stem cells and transformed cells, etc, has announced today the launch of new primary cells—Human B Cells to academic & pharmaceutical industries, as well as biotechnology organizations that are committed to biological research. 

Creative Bioarray's Human B Cells (HBC) provide a source of human antibody producing cells. HBC contain B cells from the circulation with a variety of antibody specificities. HBC are used for antibody production, studies of antigen presentation function and many other facets of immunology
Creative Bioarray's HBC are cryopreserved immediately following purification from HPBMC. Our HBC are quality tested via flow cytometry to ensure proper expression of CD19 and depletion of undesired cell types. HBC express CD19 but lack CD3, CD14 or CD56. 
Cell Features:
HBC are cryopreserved upon isolation and purification.
HBC are extensively tested for quality and optimal performance.
Creative Bioarray guarantees performance and quality.
"This newly released cells provide researchers tools that can significantly contribute to diseases study," said said Dr. Hannah Cole, the senior scientific officer of R&D department of Creative Bioarray. "These new lines also provide more convenience than currently available for assessment of compound toxicity and efficacy, which can expedite drug development and considerably reduce cost."
For more detailed information on the newly released Human B Cells, please contact Creative Bioarray by calling 1-631-626-9181, or via e-mail at 

0 Comment - Show Original Post

There is currently no comment on this blog post.

Leave your comment
To post comment, please login first.
Login Now